Weight-loss drug boom raises questions about the pharmaceutical industry

publicat 2026-05-06 00:00:08 (Bursa)
The spectacular increase in demand for obesity and diabetes dRUGS, especially those in the GLP-1 class, is starting to raise concerns about the emergence of a possible 'bubble and #8221; in the pharmaceutical industry, according to a report by Deloitte and cited by CNBC. ...continuare.

Johnson and Johnson accelerates drug development with artificial intelligence

publicat 2026-04-29 00:00:13 (Bursa)
American pharmaceutical giant Johnson and Johnson is increasingly relying on artificial intelligence to significantly reduce the time required to research and develop new treatments, at a time when the pharmaceutical industry is looking for solutions to shorten extremely expensive and time-consuming processes. According to the company and #39;s IT director, Jim Swanson, quoted by Reuters, AI has already managed to halve the time required to identify promising leads for the development of... ...continuare.

Analysis: DRUGS, limited benefits in Alzheimer and #39;s disease

publicat 2026-04-20 00:00:21 (Bursa)
DRUGS developed to slow the progression of Alzheimer and #39;s disease may have a much smaller impact than initially hoped, according to a recent analysis carried out under the auspices of Cochrane. ...continuare.

Avalyn Pharma seeks capital for studies of its inhaled dRUGS

publicat 2026-04-20 00:00:20 (Bursa)
* Massachusetts-based biotech seeks funding to develop inhaled therapies for lung diseases ...continuare.
EMAG


© Copyright 2000-2026 iStorm. Toate drepturile rezervate.